{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:55:44Z","timestamp":1780088144656,"version":"3.54.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,4,27]],"date-time":"2010-04-27T00:00:00Z","timestamp":1272326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2010,4,27]],"date-time":"2010-04-27T00:00:00Z","timestamp":1272326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s10637-010-9430-6","type":"journal-article","created":{"date-parts":[[2010,4,26]],"date-time":"2010-04-26T04:04:59Z","timestamp":1272254699000},"page":"827-832","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Liquid crystal-related compound-induced cell growth suppression and apoptosis in the chronic myelogenous leukemia K562 cell line"],"prefix":"10.1007","volume":"29","author":[{"given":"Yukako","family":"Fukushi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaharu","family":"Hazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Yoshizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuo","family":"Kashiwakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,4,27]]},"reference":[{"key":"9430_CR1","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1124\/mol.106.025866","volume":"70","author":"H Uga","year":"2006","unstructured":"Uga H, Kuramori C, Ohta A, Tsuboi Y, Tanaka H, Hatakeyama M, Yamaguchi Y, Takahashi T, Kizaki M, Hanada H (2006) A new mechanism of methotrexate action revealed by target screening with affinity beads. Mol Pharm 70:1832\u20131839","journal-title":"Mol Pharm"},{"key":"9430_CR2","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrc2167","volume":"7","author":"L Kelland","year":"2007","unstructured":"Kelland L (2007) The resurgence of platinum-based cancer chemotherapy. Nat Rev 7:573\u2013584","journal-title":"Nat Rev"},{"key":"9430_CR3","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1517\/14712598.8.6.759","volume":"8","author":"SY Wang","year":"2008","unstructured":"Wang SY, Weiner G (2008) Complement and cellular cytotoxicity in antibody therapy of cancer. Expert Opin Biol Ther 8:759\u2013768","journal-title":"Expert Opin Biol Ther"},{"key":"9430_CR4","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1158\/1535-7163.MCT-09-0366","volume":"8","author":"EA Perez","year":"2009","unstructured":"Perez EA (2009) Microtubule inhibitors: differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance. Mol Cancer Ther 8:2086\u20132095","journal-title":"Mol Cancer Ther"},{"key":"9430_CR5","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1517\/13543780903119167","volume":"18","author":"O Metzger-Filho","year":"2009","unstructured":"Metzger-Filho O, Moulin C, De Azambuja E, Ahamad A (2009) Larotaxel: broadening the road with new taxanes. Expert Opin Investig Drugs 18:1183\u20131189","journal-title":"Expert Opin Investig Drugs"},{"key":"9430_CR6","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/cmdc.200900394","volume":"5","author":"K Skobridis","year":"2010","unstructured":"Skobridis K, Kinigopoulou M, Theodorou V, Giannousi E, Russell A, Chauhan R, Sala R, Brownlow N, Kiriakdis S, Domin J, Tzakos AG, Dibb NJ (2010) Novel imatinib derivatives with altered specificity between bcr-abl and FMS, KIT, and PDGF receptors. Chem Med Chem 5:130\u2013139","journal-title":"Chem Med Chem"},{"key":"9430_CR7","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/j.1460-2075.1994.tb06319.x","volume":"13","author":"L Puil","year":"1994","unstructured":"Puil L, Liu J, Gish G, Mbamalu G, Bowtell D, Pelicci PG, Arlinghaus R, Pawson T (1994) Bcr-Abl oncoproteins bind directly to activators of the Ras signaling pathway. EMBO J 13:764\u2013773","journal-title":"EMBO J"},{"key":"9430_CR8","doi-asserted-by":"publisher","first-page":"6151","DOI":"10.1093\/emboj\/16.20.6151","volume":"16","author":"T Skorski","year":"1997","unstructured":"Skorski T, Bellacosa A, Nieborowska-Skorska M, Majewski M, Martinez R, Choi JK, Trotta R, Wlodarski P, Perrotti D, Chan TO, Wasik MA, Tsichlis PN, Calabretta B (1997) Transformation of hematopoietic cells by BCR\/ABL requires activation of a PI-3k\/Akt-dependent pathway. EMBO J 16:6151\u20136161","journal-title":"EMBO J"},{"key":"9430_CR9","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1056\/NEJM200104053441402","volume":"344","author":"BJ Druker","year":"2001","unstructured":"Druker BJ, Sawyers CL, Kantarjian H, Resta DJ, Reese SF, Ford JM, Capdeville R, Talpaz M (2001) Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N Engl J Med 344:1038\u20131042","journal-title":"N Engl J Med"},{"key":"9430_CR10","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.bbamcr.2006.10.001","volume":"1773","author":"JA McCubrey","year":"2007","unstructured":"McCubrey JA, Steelman LS, Chappell WH, Abrams SL, WT WE, Chang F, Lehmann B, Terrian DM, Milella M, Tafuri A, Stivala F, Libra M, Basecke J, Evangelisti C, Martelli AM, Franklin RA (2007) Roles of the Raf\/MEK\/ERK pathway in cell growth, malignant transformation and drug reasistance. Biochim Biophys Acta 1773:1263\u20131284","journal-title":"Biochim Biophys Acta"},{"key":"9430_CR11","first-page":"223","volume":"2","author":"C Fava","year":"2008","unstructured":"Fava C, Kantarjian H, Cortes J, Jabbour E (2008) Development and targeted use of nilotinib in chronic myeloid leukemia. Drug Des Devel Ther 2:223\u2013243","journal-title":"Drug Des Devel Ther"},{"key":"9430_CR12","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/107327480901600202","volume":"16","author":"LA Hazlehurst","year":"2009","unstructured":"Hazlehurst LA, Bewry NN, Nair RR, Pinilla-lbarz J (2009) Signaling networks associated with bcr-abl-dependent transformation. Cancer Control 16:100\u2013107","journal-title":"Cancer Control"},{"key":"9430_CR13","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.beha.2009.05.004","volume":"22","author":"A Hochhaus","year":"2009","unstructured":"Hochhaus A, Schenk T, Erben P, Ernst T, Ros\u00e9e P, M\u00fcller M (2009) Cause and management of therapy resistance. Best Pract Res Clin Haematol 22:577\u2013582","journal-title":"Best Pract Res Clin Haematol"},{"key":"9430_CR14","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1002\/jps.20435","volume":"94","author":"CL Stevenson","year":"2005","unstructured":"Stevenson CL, Bennet DB, Lechuga-Ballesteros D (2005) Pharmaceutical liquid crystals: the relevance of partially ordered systems. J Pharm Sci 94:1861\u20131880","journal-title":"J Pharm Sci"},{"key":"9430_CR15","doi-asserted-by":"publisher","first-page":"11743","DOI":"10.1021\/la8017612","volume":"24","author":"MK Dymond","year":"2008","unstructured":"Dymond MK, Attard GS (2008) Cationic Type \u0406 amphiphiles as modulators of membrane curvature elastic stress in vivo. Langmuir 24:11743\u201311751","journal-title":"Langmuir"},{"key":"9430_CR16","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1248\/bpb.32.976","volume":"32","author":"R Terasawa","year":"2009","unstructured":"Terasawa R, Fukushi Y, Monzen S, Miura T, Takahashi K, Yoshizawa A, Kashiwakura I (2009) The promoting activity on human megakaryocytopoiesis and thrombopoiesis by liquid crystal-related compounds. Biol Pharm Bull 32:976\u2013981","journal-title":"Biol Pharm Bull"},{"key":"9430_CR17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s10637-008-9141-4","volume":"27","author":"M Hazawa","year":"2009","unstructured":"Hazawa M, Wada K, Takahashi K, Mori T, Kawahara N, Kashiwakura I (2009) Suppressive effects of novel derivatives prepared from aconitum alkaloids on tumor growth. Invest New Drugs 27:111\u2013119","journal-title":"Invest New Drugs"},{"key":"9430_CR18","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.2174\/156802606777951073","volume":"6","author":"KL Kirk","year":"2006","unstructured":"Kirk KL (2006) Selective fluorination in drug design and development: an overview of biochemical rationales. Curr Top Med Chem 6:1447\u20131456","journal-title":"Curr Top Med Chem"},{"key":"9430_CR19","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1016\/j.bmcl.2007.01.006","volume":"17","author":"PJ Crocker","year":"2007","unstructured":"Crocker PJ, Mahadevan A, Wiley JL, Martin BR, Razdan RK (2007) The role of fluorine substitution in the structure\u2013activity relationships (SAR) of classical cannabinoids. Bioorg Med Chem Lett 17:1504\u20131507","journal-title":"Bioorg Med Chem Lett"},{"key":"9430_CR20","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1126\/science.270.5240.1326","volume":"270","author":"Z Xia","year":"1995","unstructured":"Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME (1995) Opposing effects of ERK and JNK-p38 MAP kinase on apoptosis. Science 270:1326\u20131331","journal-title":"Science"},{"key":"9430_CR21","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00277-006-0098-0","volume":"85","author":"G Zhang","year":"2006","unstructured":"Zhang G, Fu Y (2006) Antiproliferative effect of indomethacin on CML cells is related to the suppression of STATs\/Bcl-xL signal pathway. Ann Hematol 85:443\u2013449","journal-title":"Ann Hematol"},{"key":"9430_CR22","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/emm.2006.51","volume":"38","author":"SH Yang","year":"2006","unstructured":"Yang SH, Chien CM, Lu MC, Lin YH, Hu XW, Lin SR (2006) Up-regulation of Bax and endonuclease G, and down-modulation of Bcl-xL involved in cardiotoxin III-induced apoptosis in K562 cells. Exp Mol Med 38:435\u2013444","journal-title":"Exp Mol Med"},{"key":"9430_CR23","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1080\/10428190701583991","volume":"48","author":"Y Meng","year":"2007","unstructured":"Meng Y, Li Y, Li J, Li H, Fu J, Liu Y, Liu H, Chen X (2007) (-)Gossypol and its combination with imatinib induce apoptosis in human chronic myeloid leukemic cells. Leuk Lymphoma 48:2204\u20132212","journal-title":"Leuk Lymphoma"},{"key":"9430_CR24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.taap.2003.08.017","volume":"194","author":"MJ Liu","year":"2004","unstructured":"Liu MJ, Li HX, Wu RC, Liu YZ, Wu QY (2004) Mitochondrial dysfunction as an early event in the process of apoptosis induced by woodfordin Iin human leukemia K562 cells. Toxicol Appl Pharm 194:141\u2013155","journal-title":"Toxicol Appl Pharm"},{"key":"9430_CR25","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/cr.2008.86","volume":"18","author":"X Mao","year":"2008","unstructured":"Mao X, Yu CR, Li WH, Li WX (2008) Induction of apoptosis by shikonin through a ROS\/JNK-mediated process in Bcr\/Abl-positive chronic myelogenous leukemia (CML) cells. Cell Res 18:879\u2013888","journal-title":"Cell Res"},{"key":"9430_CR26","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1246\/cl.2009.310","volume":"38","author":"A Yoshizawa","year":"2009","unstructured":"Yoshizawa A, Takahashi Y, Terasawa R, Shota C, Takahashi K, Haawa M, Kashiwakura I (2009) Liquid crystallinity and biological activity of a novel amphiphilic compound. Chem Lett 38:310\u2013311","journal-title":"Chem Lett"},{"key":"9430_CR27","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1246\/cl.2009.530","volume":"38","author":"A Yoshizawa","year":"2009","unstructured":"Yoshizawa A, Takahashi Y, Terasawa R, Shota C, Takahashi K, Haawa M, Kashiwakura I (2009) Biological activity of some cyanobiphenyl derivatives. Chem Lett 38:530\u2013531","journal-title":"Chem Lett"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-010-9430-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-010-9430-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-010-9430-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-010-9430-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T04:57:12Z","timestamp":1678510632000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-010-9430-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,27]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["9430"],"URL":"https:\/\/doi.org\/10.1007\/s10637-010-9430-6","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,27]]},"assertion":[{"value":"26 February 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}